Dr. Platt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Robert Wood Johnson Pl
# Meb
New Brunswick, NJ 08901Phone+1 732-235-7742
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Infectious Disease, 2012 - 2014
- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2008 - 2011
- Rutgers New Jersey Medical SchoolClass of 2008
Certifications & Licensure
- NJ State Medical License 2010 - 2025
- NY State Medical License 2012 - 2015
Publications & Presentations
PubMed
- 230 citationsEfficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): A non-randomised, op...Jürgen K. Rockstroh, Mark T. Nelson, Christine Katlama, J. Lalezari, Josep Mallolas
The Lancet. HIV. 2015-08-01 - 296 citationsElbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized TrialGregory J. Dore, Frederick L. Altice, Alain H. Litwin, Olav Dalgard, Edward Gane
Annals of Internal Medicine. 2016-11-01 - 37 citationsEfficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trialJan Sperl, Gabor Horvath, Waldemar Halota, Juan Ignacio Arenas Ruiz-Tapiador, Anca Streinu-Cercel
Journal of Hepatology. 2016-12-01
Press Mentions
- Emerging Infectious Diseases Prompt a Layered ResponseAugust 16th, 2023
- Pancreatic Cancer Clinical Trials: Insights from PanCAn’s Senior DirectorDecember 16th, 2023
- CMV Vaccine Trials: Moderna’s CMV mRNA Vaccine Enters Phase IIIFebruary 20th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: